Literature DB >> 28081470

Inhibition viral RNP and anti-inflammatory activity of coumarins against influenza virus.

YuTao Wang1, Wen Yan2, QiaoLian Chen1, WanYi Huang1, Zifeng Yang3, Xiong Li4, XinHua Wang5.   

Abstract

Influenza viruses pose a severe threat to human health and a significant increase in antiviral drug-resistant among influenza viruses worldwide has been observed. Therefore, there is an urgent need to develop the new antiviral drugs, specifically from the natural products. In this study, the anti-viral and anti-inflammatory activities of coumarins against influenza A virus in vitro were investigated. One of the derivatives eleutheroside B1 showed a wide spectrum of anti- human influenza virus effect with the IC50 value of 64-125μg/ml in vitro, but it showed no effects against avian influenza virus. The time of addition was done and the results indicated that it had a potent antiviral effect when added at 0-6h, and also the virus yield was reduced by 60%. The influenza virus ribonucleoprotein was inhibited at 200μg/ml, and also the NP mRNA expression was inhibited at 50 and 200μg/ml. The expression level of cytokines and chemokines influenced by eleutheroside B1 was further demonstrated, the IL-6, CXCL-8, CCL-2 expression were all inhibited by the eleuthe roside B1 at concentration 200μg/ml. The findings of study suggest that eleutheroside B1 can be as potential agent to develop for the prevention and treatment of influenza A virus.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anti-inflammatory; Coumarins; Eleutheroside B(1); Influenza virus; Viral ribonucleoprotein

Mesh:

Substances:

Year:  2017        PMID: 28081470     DOI: 10.1016/j.biopha.2016.12.117

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

Review 1.  The Traditional Uses, Phytochemistry and Pharmacology of Sarcandra glabra (Thunb.) Nakai, a Chinese Herb With Potential for Development: Review.

Authors:  Yuanlian Zeng; Junyu Liu; Qiang Zhang; Xuhua Qin; Zulun Li; Guojuan Sun; Shenrui Jin
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

2.  Effect of eleutheroside B1 on non‑coding RNAs and protein profiles of influenza A virus‑infected A549 cells.

Authors:  Wen Yan; Jing Chen; Zhenquan Wei; Xiaohu Wang; Zhiqi Zeng; Dumizulu Tembo; Yutao Wang; Xinhua Wang
Journal:  Int J Mol Med       Date:  2020-01-17       Impact factor: 4.101

3.  Arylcoumarin perturbs SARS-CoV-2 pathogenesis by targeting the S-protein/ACE2 interaction.

Authors:  Ruhar Singh; Abhijeet Kumar; Jitendra Subhash Rane; Rajni Khan; Garima Tripathi; Amrendra K Ajay; Amresh Prakash; Shashikant Ray
Journal:  Sci Rep       Date:  2022-10-11       Impact factor: 4.996

Review 4.  Host-Virus Interaction: How Host Cells Defend against Influenza A Virus Infection.

Authors:  Yun Zhang; Zhichao Xu; Yongchang Cao
Journal:  Viruses       Date:  2020-03-29       Impact factor: 5.048

5.  Eleutheroside B1 mediates its anti-influenza activity through POLR2A and N-glycosylation.

Authors:  Wen Yan; Chunge Zheng; Jiayang He; Wenjie Zhang; Xin-An Huang; Xiong Li; Yutao Wang; Xinhua Wang
Journal:  Int J Mol Med       Date:  2018-09-07       Impact factor: 4.101

6.  Coumarin: An emerging antiviral agent.

Authors:  Shruti Mishra; Achyut Pandey; Siddharth Manvati
Journal:  Heliyon       Date:  2020-01-27

7.  Triterpenes and Phenolic Compounds from Euphorbia deightonii with Antiviral Activity against Herpes Simplex Virus Type-2.

Authors:  Muhammad Bello Saidu; Norbert Kúsz; Yu-Chi Tsai; Máté Vágvölgyi; Róbert Berkecz; Dávid Kókai; Katalin Burián; Judit Hohmann; Dóra Rédei
Journal:  Plants (Basel)       Date:  2022-03-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.